{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:04:24Z","timestamp":1791417864029,"version":"4.3.3"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education of the Republic of Korea","doi-asserted-by":"publisher","award":["RS-2025-00556282"],"award-info":[{"award-number":["RS-2025-00556282"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2025-25458787"],"award-info":[{"award-number":["RS-2025-25458787"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Topical corticosteroids (TCS) are widely used anti-inflammatory treatments for various dermatological conditions. Although they are generally considered safe, concerns remain regarding systemic absorption and potentially increase the risk of type 2 diabetes mellitus (T2DM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the association between TCS exposure \u2013 considering potency, cumulative duration and prescription frequency \u2013 and the prospective risk of developing T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a population-based longitudinal cohort study using the National Health Insurance Service database of South Korea. A total of 685 389 adults aged \u2265 20\u2005years without diabetes at baseline were included. TCS exposure was assessed over a 5-year period based on any TCS use and further characterized by potency, cumulative duration and prescription frequency, followed by a 6-year outcome ascertainment period. Incident T2DM was defined as the presence of an International Classification of Diseases, 10th Revision code (E11\u2013E14) accompanied by at least one prescription for antidiabetic medication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall TCS use during a 5-year exposure period was not associated with an increased risk of T2DM after adjusting for potential confounders. However, potent TCS use [adjusted hazard ratio (aHR) 1.15, 95% confidence interval (CI) 1.04\u20131.26], higher prescription frequency (\u2265 10 prescriptions) (aHR 1.26, 95% CI 1.12\u20131.42) and longer cumulative duration of exposure (\u2265 6\u2005months) (aHR 1.45, 95% CI 1.25\u20131.67) were associated with a higher risk of developing T2DM. In contrast, low-potency TCS use, exposure duration &amp;lt; 6\u2005months, and &amp;lt; 10 TCS prescriptions were associated with a lower risk of T2DM (aHR 0.83, 95% CI 0.75\u20130.91; aHR 0.95, 95% CI 0.90\u20130.99; aHR 0.94, 95% CI 0.90\u20130.99, respectively).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this large nationwide cohort, overall TCS use was not associated with incident T2DM. However, the use of high-potency formulations, longer cumulative duration and frequent prescriptions were associated with an increased risk of T2DM. These findings underscore the importance of prudent prescribing and targeted metabolic monitoring in patients requiring potent or long-term TCS therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/bjd\/ljag165","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T11:31:48Z","timestamp":1777203108000},"page":"431-440","source":"Crossref","is-referenced-by-count":2,"title":["Topical corticosteroid use and risk of type\u00a02 diabetes mellitus: a nationwide cohort study"],"prefix":"10.1093","volume":"195","author":[{"given":"Ha-Na","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Family Medicine, St. Vincent\u2019s Hospital, College of Medicine, The Catholic University of Korea , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3671-502X","authenticated-orcid":false,"given":"Ji Hyun","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Seoul St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjong","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Data Science, Hanmi Pharmaceutical , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3063-8024","authenticated-orcid":false,"given":"Hoseob","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Data Science, Hanmi Pharmaceutical , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-5019","authenticated-orcid":false,"given":"Sang-Wook","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, St. Vincent\u2019s Hospital, College of Medicine, The Catholic University of Korea , Seoul ,","place":["Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"Suppl.","key":"2026081811172746400_ljag165-B1","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes \u2013 2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"key":"2026081811172746400_ljag165-B2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"2026081811172746400_ljag165-B3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications","volume":"26","author":"Dal Canto","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026081811172746400_ljag165-B4","doi-asserted-by":"crossref","first-page":"120","DOI":"10.4239\/wjd.v8.i4.120","article-title":"Type 2 diabetes and quality of life","volume":"8","author":"Trikkalinou","year":"2017","journal-title":"World J Diabetes"},{"key":"2026081811172746400_ljag165-B5","doi-asserted-by":"crossref","first-page":"2322107","DOI":"10.1080\/20523211.2024.2322107","article-title":"A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middle-income countries","volume":"17","author":"Butt","year":"2024","journal-title":"J Pharm Policy Pract"},{"key":"2026081811172746400_ljag165-B6","doi-asserted-by":"crossref","first-page":"1247705","DOI":"10.3389\/fcvm.2023.1247705","article-title":"The global burden of cardiovascular diseases and type 2 diabetes attributable to low physical activity, 1990-2019: an analysis from the global burden of disease study","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026081811172746400_ljag165-B7","doi-asserted-by":"crossref","first-page":"561018","DOI":"10.1155\/2012\/561018","article-title":"Mechanisms of action of topical corticosteroids in psoriasis","volume":"2012","author":"Uva","year":"2012","journal-title":"Int J Endocrinol"},{"key":"2026081811172746400_ljag165-B8","article-title":"Topical corticosteroids","volume-title":"StatPearls","author":"Gabros"},{"key":"2026081811172746400_ljag165-B9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","article-title":"The 500 Dalton rule for the skin penetration of chemical compounds and drugs","volume":"9","author":"Bos","year":"2000","journal-title":"Exp Dermatol"},{"key":"2026081811172746400_ljag165-B10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/bjd.15065","article-title":"Skin absorption through atopic dermatitis skin: a systematic review","volume":"177","author":"Halling-Overgaard","year":"2017","journal-title":"Br J Dermatol"},{"key":"2026081811172746400_ljag165-B11","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","article-title":"Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions","volume":"18","author":"Li","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"2026081811172746400_ljag165-B12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2337\/dc18-2158","article-title":"Association between topical corticosteroid use and type 2 diabetes in two European population-based adult cohorts","volume":"42","author":"Andersen","year":"2019","journal-title":"Diabetes Care"},{"key":"2026081811172746400_ljag165-B13","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/09546634.2019.1657224","article-title":"Topical corticosteroids and risk of diabetes mellitus: systematic review and meta-analysis","volume":"32","author":"Phan","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"2026081811172746400_ljag165-B14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2165\/00002018-200932060-00008","article-title":"Topical corticosteroids and the risk of diabetes mellitus: a nested case-control study in the Netherlands","volume":"32","author":"van der Linden","year":"2009","journal-title":"Drug Saf"},{"key":"2026081811172746400_ljag165-B15","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/all.15690","article-title":"Effects of topical corticosteroid versus tacrolimus on insulin sensitivity and bone homeostasis in adults with atopic dermatitis - a randomized controlled study","volume":"78","author":"Gether","year":"2023","journal-title":"Allergy"},{"key":"2026081811172746400_ljag165-B16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.12997\/jla.2022.11.2.103","article-title":"Understanding and utilizing claim data from the Korean National Health Insurance Service (NHIS) and Health Insurance Review & Assessment (HIRA) database for research","volume":"11","author":"Kyoung","year":"2022","journal-title":"J Lipid Atheroscler"},{"key":"2026081811172746400_ljag165-B17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2005.12.028","article-title":"Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity","volume":"54","author":"Jacob","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"2026081811172746400_ljag165-B18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1017\/S1368980008002802","article-title":"Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians","volume":"12","author":"Wen","year":"2009","journal-title":"Public Health Nutr"},{"key":"2026081811172746400_ljag165-B19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/pds.5623","article-title":"Pragmatic considerations for negative control outcome studies to guide non-randomized comparative analyses: a narrative review","volume":"32","author":"Levintow","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026081811172746400_ljag165-B20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026081811172746400_ljag165-B21","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.2337\/dc06-1499","article-title":"Risk of diabetes associated with prescribed glucocorticoids in a large population","volume":"29","author":"Gulliford","year":"2006","journal-title":"Diabetes Care"},{"key":"2026081811172746400_ljag165-B22","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI107473","article-title":"Influence of glucocorticoids on glucagon secretion and plasma amino acid concentrations in man","volume":"52","author":"Wise","year":"1973","journal-title":"J Clin Invest"},{"key":"2026081811172746400_ljag165-B23","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI111141","article-title":"An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects","volume":"72","author":"Pagano","year":"1983","journal-title":"J Clin Invest"},{"key":"2026081811172746400_ljag165-B24","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/dc12-0702","article-title":"Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"2026081811172746400_ljag165-B25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2017.10.050","article-title":"Psoriasis and the risk of diabetes: a prospective population-based cohort study","volume":"78","author":"Wan","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2026081811172746400_ljag165-B26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/pds.5407","article-title":"Core concepts in pharmacoepidemiology: confounding by indication and the role of active comparators","volume":"31","author":"Sendor","year":"2022","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2026081811172746400_ljag165-B27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/CLEP.S129879","article-title":"Confounding in observational studies based on large health care databases: problems and potential solutions - a primer for the clinician","volume":"9","author":"N\u00f8rgaard","year":"2017","journal-title":"Clin Epidemiol"},{"key":"2026081811172746400_ljag165-B28","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","article-title":"Background and data configuration process of a nationwide population-based study using the Korean National Health Insurance system","volume":"38","author":"Song","year":"2014","journal-title":"Diabetes Metab J"},{"key":"2026081811172746400_ljag165-B29","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaci.2017.01.027","article-title":"Molecular signatures order the potency of topically applied anti-inflammatory drugs in patients with atopic dermatitis","volume":"140","author":"Guttman-Yassky","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2026081811172746400_ljag165-B30","author":"National Institute for Health and Care Excellence"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljag165\/68173341\/ljag165.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/195\/3\/431\/68173341\/ljag165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/195\/3\/431\/68173341\/ljag165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:23:04Z","timestamp":1787066584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/195\/3\/431\/8663805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,4,28]]},"published-print":{"date-parts":[[2026,8,18]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljag165","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,4,28]]}}}